Study identifier:NIS-EG-CRE-2010/01
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Centralized Pan-Middle East Survey on the Undertreatment of Hypercholesterolemia
Hypercholesterolemia
-
No
-
All
1000
Observational
18 Years +
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 May 2012 by AstraZeneca
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|---|
HYPERCHOLESTEROLEMIC PATIENTS | - |